Jan Turek

JAN TUREK, President and Chief Executive Officer, Member of Board of
Directors of Biolex. Mr. Turek has over 25 years experience in the
pharmaceutical industry. Prior to joining Biolex, he was Senior Vice-
President and General Manager for the Biological Products Business Unit
of Bayer Corporation, a unit dedicated to therapeutic proteins. He has
extensive experience in directing research, development, manufacturing
and marketing of therapeutic proteins and small molecules. His previous
experience was with Bristol Myers and Sandoz, where he held various
positions of increasing responsibility. He has extensive international
experience, having worked in Canada and Germany. Mr. Turek received his
Bachelor of Science degree in Biochemistry from McGill University in
Montreal Canada.